Comparative genomic hybridization analysis of newly established retinoblastoma cell lines of adherent growth compared with Y79 of nonadherent growth

Journal of Pediatric Hematology/Oncology

Volumn 30, Issue 8, 2008, Pages 571-574

  Jeong, Hun Kim ^a   Jin, Hyoung Kim ^a   Young, Suk Yu ^a   Dong, Hun Kim ^b   Yong, Kyu Kim ^a   Kim, Kyu Won ^a  

^a Seoul National University   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Adherent growth; Comparative genomic hybridization; Retinoblastoma; SNUOT RB1 and SNUOT RB4; Y79

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CCND1 GENE; CELL ADHESION; CELL GROWTH; CHILD; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 11Q; CHROMOSOME 16; CHROMOSOME 16Q; CHROMOSOME 17; CHROMOSOME 2P; CHROMOSOME 3; CHROMOSOME 9; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYLD GENE; FGF3 GENE; GENE LOCUS; GENE LOSS; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MEN1 GENE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOBLASTOMA; TUMOR GENE; TUMOR SUPPRESSOR GENE; CELL PROLIFERATION; DNA MICROARRAY; GENE DOSAGE; GENETICS; NUCLEIC ACID HYBRIDIZATION; PHYSIOLOGY; TUMOR CELL LINE;

RETINOBLASTOMA PROTEIN;

CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; GENE DOSAGE; GENES, RETINOBLASTOMA; HUMANS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN;

EID: 53749104027     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31816e232d     Document Type: Article

References (31)

1. Newsham IF, Hadjistilianou T, Cavene WK. Retinoblastoma. In: Vogelstein B, Kinzler KW, eds. The Genetic Basis of Cancer. New York: McGraw-Hill; 1998:363-393.
2. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA. 1971;68:820-823.
3. Yunis JJ, Ramsay N. Retinoblastoma and subband deletion of chromosome 13. Am J Dis Child. 1978;132:161-163.
4. Blanquet V, Turleau C, de Grouchy J, et al. Physical map around the retinoblastoma gene: possible genomic imprinting suggested by NruI digestion. Genomics. 1991;10:350-355.
5. Wiggs J, Nordenskjold M, Yandell D, et al. Prediction of the risk of hereditary retinoblastoma, using DNA polymorphisms within the retinoblastoma gene. N Engl J Med. 1988;318:151-157.
6. Harbour JW, Dean DC. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol. 2000;2:65-67.
7. Lee EY, Chang CY, Hu N, et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature. 1992; 359:288-294.
8. Morgenbesser SD, Williams BO, Jacks T, et al. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature. 1994;371:72-74.
9. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992;258:818-821.
10. Kim JH, Kim JH, Yu YS, et al. Establishment and characterization of a novel, spontaneously immortalized retinoblastoma cell line with adherent growth. Int J Oncol. 2007;31:585-592.
11. Reid TW, Albert DM, Rabson AS, et al. Characteristics of an established cell line of retinoblastoma. J Natl Cancer Inst. 1974;53: 347-360.
12. Pession A, Tonelli R. The MYCN oncogene as a specific and selective drug target for peripheral and central nervous system tumors. Curr Cancer Drug Targets. 2005;5:273-283.
13. LeeWH, Murphree AL, BenedictWF. Expression and amplification of the N-myc gene in primary retinoblastoma. Nature. 1984;309:458-460.
14. Yokoyama T, Tsukahara T, Nakagawa C, et al. The N-myc gene product in primary retinoblastomas. Cancer. 1989;63:2134-2138.
15. Doz F, Peter M, Schleiermacher G, et al. N-MYC amplification, loss of heterozygosity on the short arm of chromosome 1 and DNA ploidy in retinoblastoma. Eur J Cancer. 1996;32:645-649.
16. Kim CJ, Chi JG, Choi HS, et al. Proliferation not apoptosis as a prognostic indicator in retinoblastoma. Virchows Arch. 1999;434: 301-305.
17. Hinds PW, Dowdy SF, Eaton EN, et al. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA. 1994;91:709-713.
18. Muller H, Lukas J, Schneider A, et al. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA.1994;91:2945-2949.
19. van Damme H, Brok H, Schuuring-Scholtes E, et al. The redistribution of cortactin into cell-matrix contact sites in human carcinoma cells with 11q13 amplification is associated with both overexpression and post-translational modification. J Biol Chem.1997;272:7374-7380.
20. Schuuring E, van Damme H, Schuuring-Scholtes E, et al. Characterization of the EMS1 gene and its product, human Cortactin. Cell Adhes Commun. 1998;6:185-209.
21. Tai AL, Sham JS, Xie D, et al. Co-overexpression of fibroblast growth factor 3 and epidermal growth factor receptor is correlated with the development of nonsmall cell lung carcinoma. Cancer.2006;106:146-155.
22. Pekarsky Y, Palamarchuk A, Huebner K, et al. FHIT as tumor suppressor: mechanisms and therapeutic opportunities. Cancer Biol Ther. 2002;1:232-236.
23. Iliopoulos D, Guler G, Han SY, et al. Roles of FHIT and WWOX fragile genes in cancer. Cancer Lett. 2006;232:27-36.
24. Lukas J, Parry D, Aagaard L, et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature. 1995;375:503-506.
25. Koh J, Enders GH, Dynlacht BD, et al. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature. 1995;375: 506-510.
26. Lee MH, Reynisdottir I, Massague J. Cloning of p57KIP2, a cyclindependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 1995;9:639-649.
27. Biggs PJ, Wooster R, Ford D, et al. Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene. Nat Genet. 1995;11: 441-443.
28. Kovalenko A, Chable-Bessia C, Cantarella G, et al. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature. 2003;424:801-805.
29. Brummelkamp TR, Nijman SM, Dirac AM, et al. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature. 2003;424:797-801.
30. Trompouki E, Hatzivassiliou E, Tsichritzis T, et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature. 2003;424:793-796.
31. Laurie NA, Donovan SL, Shih CS, et al. Inactivation of the p53 pathway in retinoblastoma. Nature. 2006;444:61-66.